| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.009 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |